THE EFFECT OF DPP4 INHIBITOR ON RENAL ANEMIA IN HEMODIALYSIS PATIENTS

被引：0
作者：
Aono, Masaki [1 ]
Sato, Yuzuru [1 ]
机构：
[1] Sato Junkanki Hosp, Internal Med, Matsuyama, Ehime, Japan
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2015年 / 30卷
关键词：
D O I：
10.1093/ndt/gfv182.4
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
FP656
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Linagliptine, a new inhibitor of DPP4: no need for dosage adjustment in patients with renal failure
    Graefe-Mody, U.
    Friedrich, C.
    Port, A.
    Ring, A.
    Heise, T.
    Halabi, A.
    Tocque-le Gousse, E.
    Woedel, H. -J.
    DIABETES & METABOLISM, 2011, 37 : A108 - A108
  • [2] Reduction of cardiac and renal dysfunction by new inhibitor of DPP4 in diabetic rats
    Bryelle E. O. Alves
    Allan K. N. de Alencar
    Luis E. R. Gamba
    Margarete M. Trachez
    Jaqueline S. da Silva
    Josenildo S. C. Araújo
    Tadeu L. Montagnoli
    Luiza V. P. Mendes
    Pedro M. Pimentel-Coelho
    Valéria do M. N. Cunha
    Rosalia Mendez-Otero
    Gláucia M. M. Oliveira
    Lídia M. Lima
    Eliezer J. Barreiro
    Roberto T. Sudo
    Gisele Zapata-Sudo
    Pharmacological Reports, 2019, 71 : 1190 - 1200
  • [3] Reduction of cardiac and renal dysfunction by new inhibitor of DPP4 in diabetic rats
    Alves, Bryelle E. O.
    de Alencar, Allan K. N.
    Gamba, Luis E. R.
    Trachez, Margarete M.
    da Silva, Jaqueline S.
    Araujo, Josenildo S. C.
    Montagnoli, Tadeu L.
    Mendes, Luiza V. P.
    Pimentel-Coelho, Pedro M.
    Cunha, Valeria do M. N.
    Mendez-Otero, Rosalia
    Oliveira, Glaucia M. M.
    Lima, Lidia M.
    Barreiro, Eliezer J.
    Sudo, Roberto T.
    Zapata-Sudo, Gisele
    PHARMACOLOGICAL REPORTS, 2019, 71 (06) : 1190 - 1200
  • [4] The role of dipeptidyl peptidase 4 (DPP4) in the preservation of renal function: DPP4 involvement in hemoglobin expression
    Sato, Youichi
    Kamada, Takanobu
    Yamauchi, Aiko
    JOURNAL OF ENDOCRINOLOGY, 2014, 223 (02) : 133 - 142
  • [5] The DPP4 inhibitor Alogliptin shown to reduce Atherosclerosis
    不详
    DIABETES OBESITY & METABOLISM, 2016, 18 (05) : 543 - 543
  • [6] DPP4 in diabetes
    Roehrborn, Diana
    Wronkowitz, Nina
    Eckel, Juergen
    FRONTIERS IN IMMUNOLOGY, 2015, 6 : 1 - 20
  • [7] DPP4 INHIBITOR, ANAGLIPTIN, AMELIORATES FASTING AND POSTPRANDIAL HYPERTRIGLYCERIDEMIA
    Sairyo, M.
    Masuda, D.
    Kobayashi, T.
    Matsuda, H.
    Okada, T.
    Kawase, R.
    Nakatani, K.
    Koseki, M.
    Ohama, T.
    Nishida, M.
    Sakata, Y.
    Yamashita, S.
    ATHEROSCLEROSIS, 2016, 252 : E213 - E213
  • [8] PARICALCITOL AND DIPEPTIDYL PEPETIDASE 4 (DPP4) INHIBITORS THE EFFECT ON RESISTIN IN TYPE 2 DIABETIC AND RENAL DISEASE PATIENTS
    Mendes, Filipa Brito
    Pereira, Luisa Helena
    Silva, Ana Paula
    Neves, Pedro
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [9] Clinical markers of glycaemic response to DPP4 inhibitor therapy
    Ivone Leong
    Nature Reviews Endocrinology, 2018, 14 : 191 - 191
  • [10] Suppression of lung cancer in mice by DPP4 inhibitor Vildagliptin
    Jang, J. -H.
    Janker, F.
    Arni, S.
    Yamada, Y.
    Gil-Bazo, I.
    De Meester, I.
    Weder, W.
    Jungraithmayr, W.
    BRITISH JOURNAL OF SURGERY, 2016, 103 : 27 - 27
12345